AACR Associate Member Council members offer advice for how graduate students can make the most of AACR resources for...
At the San Antonio Breast Cancer Symposium, experts discussed the implications of sexual health, supplements, exercise, and diet for...
In the final three months of 2024, the FDA issued 15 approvals in oncology, including several therapies that are...
This month, the editors of the AACR journals highlighted studies about the gut microbiome in lung cancer, modeling the...
In 2024, the American Association for Cancer Research (AACR) released the 14th edition of the annual AACR Cancer Progress...
A session on molecular degraders at SABCS 2024 highlighted an exciting new frontier for SERDs, PROTACs, LYTACs, and biparatopic...
By Vivek Subbiah, MD, Sarah Cannon Research Institute It is both the best of times and a challenging time...
Researchers at the 2024 San Antonio Breast Cancer Symposium discussed considerations for treating and managing of early-onset breast cancer.
When the chemotherapy drug 5-fluorouracil (5-FU) was approved in 1962, there was limited understanding of how it is metabolized...
Studies presented at the 2024 SABCS examined ways to predict responses to treatments for HR-positive, HER2-negative breast cancer.
Data from clinical trials presented at SABCS may help patients with DCIS make informed choices between different management...